Borivoje Lukic

Dr. Borivoje Lukic

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PZPetar Zlatanovic
Petar Zlatanovic
AMAmr A. Mahmoud
Amr A. Mahmoud
ICIlijas Cinara
Ilijas Cinara
VCVladimir Cvetic
Vladimir Cvetic
BLBorivoje Lukic
Borivoje Lukic
LDLazar Davidovic
Lazar Davidovic

26 April 2024 in Medicina
Verified
Journal Article
Open access
PDF file
DVDejan Velickovic
Dejan Velickovic
KSKatarina Stosic
Katarina Stosic
ASAleksandra Djuric Stefanovic
Aleksandra Djuric Stefanovic
JKJelena Kovac
Jelena Kovac
DSDanijela Sekulić
Danijela Sekulić
VCVladimir Zoran Cvetic
Vladimir Zoran Cvetic
The occurrence of the pseudoaneurysm of visceral arteries in the field of chronic pancreatitis is a very rare complication that represents a life-threatening condition. The higher frequency of this complication is in the necrotic form of pancreatic inflammation, especially in patients with formed peripancreatic necrotic collections. The degradation of the arterial wall leads to bleeding and transforms these necrotic collections into a pseudoaneurysm. Urgent endovascular angioembolization is the first choice in the therapeutic approach as a valid minimally invasive solution with very satisfactory immediate and long-term outcomes. This successfully avoids open surgery, which is associated with a high mortality rate in these patients, especially in acute-on-chronic pancreatitis.

Verified
Journal Article
Open access
PDF file
BLBorivoje Lukic
Borivoje Lukic
MMMarko Miletic
Marko Miletic
SMStefan Milošević
Stefan Milošević
MDMarko Dragas
Marko Dragas
JŠJovica Šaponjski
Jovica Šaponjski
VCVladimir Zoran Cvetic
Vladimir Zoran Cvetic
Background/Objectives: Peripheral artery disease (PAD) is a significant global health challenge, affecting millions worldwide. Among its various manifestations, femoropopliteal atherosclerotic disease presents a unique challenge due to the biomechanical stresses on the superficial femoral artery (SFA) and popliteal artery (PA). Despite advancements in endovascular interventions, restenosis and stent fractures remain critical issues, particularly in complex and long lesions. Biomimetic stents, such as the SUPERA interwoven nitinol stent, have been developed to address these challenges by closely replicating the natural mechanical properties of the femoropopliteal arteries. This study evaluates the clinical and procedural outcomes of biomimetic stent implantation in patients with femoropopliteal atherosclerotic disease, focusing on patency rates, procedural success, and major adverse limb events (MALE). Methods: A cohort study was conducted at the University Clinical Center of Serbia, including 294 patients with femoropopliteal stenosis or occlusion treated with the SUPERA stent from January 2017 to December 2024. Patients were stratified by lesion complexity using the GLASS classification and procedural success, patency rates, and MALE incidence were assessed. Kaplan–Meier survival analysis was used to evaluate long-term outcomes, and Cox regression analysis identified predictors of MALE. Results: Primary patency rates at 1, 6, 12, and 24 months were 95.6%, 90.1%, 84.2%, and 77.7%, respectively. Primary-assisted patency and secondary patency rates remained high over time. Patients with GLASS IV lesions exhibited significantly lower patency rates and higher MALE incidence compared to GLASS I-III patients (p = 0.002). Occlusion length (≥16 cm) and lesion complexity (GLASS IV) were independent predictors of MALE (p = 0.015). The stent demonstrated high procedural success and durability, with minimal complications. Conclusions: Biomimetic SUPERA stents provide high patency rates and favorable clinical outcomes in complex femoropopliteal lesions. However, lesion complexity and occlusion length significantly impact long-term success. The findings highlight the importance of careful patient selection and lesion assessment for optimizing endovascular treatment strategies in PAD management.

1 September 2020 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
VCVladimir Zoran Cvetic
Vladimir Zoran Cvetic
BLBorivoje Lukic
Borivoje Lukic

1 April 2021 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
BLBorivoje Lukic
Borivoje Lukic
VCVladimir Cvetic
Vladimir Cvetic

25 March 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PMPerica Mutavdzic
Perica Mutavdzic
TKTijana Kokovic
Tijana Kokovic
ITIvan Tomic
Ivan Tomic
DMDavid Matejevic
David Matejevic
MDMarko Dragas
Marko Dragas
IKIgor B Končar
Igor B Končar
Background/Objectives: Risk stratification in asymptomatic carotid stenosis has traditionally relied on the degree of luminal narrowing; however, plaque vulnerability may better predict cerebrovascular events. Ipsilateral silent brain lesions (SBLs) are considered surrogate markers of stroke risk. This study aimed to identify carotid plaque features on duplex ultrasound (DUS) and computed tomography angiography (CTA), as well as circulating biomarkers, associated with ipsilateral SBL in patients with clinically asymptomatic ≥70% internal carotid artery stenosis. Methods: This prospective observational study with cross-sectional imaging analysis included 316 clinically asymptomatic patients with ≥70% carotid stenosis treated between January 2022 and October 2024. All patients underwent cranial non-contrast CT for SBL detection, DUS plaque characterization (according to the Gray–Weale classification and plaque surface morphology), and CTA analysis, including plaque surface, composition, length, and attenuation values categorized according to Schroeder’s criteria (120 HU calcified). Demographic, clinical, and laboratory parameters, including inflammatory biomarkers, were recorded. Multivariate logistic regression was performed to identify independent predictors of SBL. Results: SBL were detected in 72 patients (22.8%). On DUS, SBL were significantly associated with Gray–Weale class II plaques, heterogeneous composition, and irregular or ulcerated surfaces (all p < 0.001). On CTA, lipid-rich plaques (<50 HU), ulcerated surfaces, heterogeneous morphology, and lower median plaque density were significantly more frequent in the SBL group (all p < 0.001). In multivariate analysis, independent predictors of SBL were male sex (OR 2.2; 95% CI 1.2–5.7; p = 0.029), Gray–Weale class II plaques (p = 0.002), lipid-rich plaque morphology (OR 21.39; 95% CI 6.86–66.76; p < 0.001), and ulcerated plaque surface on CTA (OR 20.62; 95% CI 7.37–57.68; p < 0.001). Conclusions: Specific ultrasound and CT plaque characteristics were associated with ipsilateral silent brain lesions in patients with asymptomatic ≥70% carotid stenosis. A multiparametric imaging approach may improve risk stratification beyond stenosis severity alone.